ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,769Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 1383

$1.32M Total Retail Price of All Prescriptions

Rank: 22 out of 1383

845 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 845 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 845 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 21,974 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
OMEPRAZOLE 1,058 811 1 5
LEVOTHYROXINE SODIUM 986 770 2 4
FUROSEMIDE 982 774 3 7
HYDROCODONE-ACETAMINOPHEN 921 525 S3 4 1
METOPROLOL TARTRATE 887 721 5 9
POTASSIUM CHLORIDE 849 666 6 12
PRAVASTATIN SODIUM 834 649 7 14
LISINOPRIL 797 551 8 3
METFORMIN HCL 747 567 9 8
WARFARIN SODIUM 710 610 10 13
ATENOLOL 675 508 11 16
AMLODIPINE BESYLATE 573 413 12 6
SERTRALINE HCL 464 374 13 21
HYDROCHLOROTHIAZIDE 445 326 14 10
NEXIUM 347 182 15 26
GABAPENTIN 340 210 16 11
TAMSULOSIN HCL 312 295 17 30
PREDNISONE 310 217 18 40
CIPROFLOXACIN HCL 307 242 19 54
RANITIDINE HCL 294 236 20 19
SPIRONOLACTONE 287 212 21 67
SIMVASTATIN 283 201 22 2
GLYBURIDE 281 244 R 23 46
VERAPAMIL ER 277 209 24 84
IBUPROFEN 272 217 25 91
TRAZODONE HCL 263 191 26 36
CLOPIDOGREL 248 212 27 28
ALLOPURINOL 233 186 28 33
AMITRIPTYLINE HCL 230 173 R 29 57
MIRTAZAPINE 212 168 30 51
NAPROXEN 211 160 31 105
CITALOPRAM HBR 211 130 31 15
LOSARTAN POTASSIUM 206 169 33 23
PLAVIX 199 170 34 43
RAMIPRIL 194 181 35 80
LANTUS 188 122 36 50
IPRATROPIUM-ALBUTEROL 174 162 37 138
PROAIR HFA 173 96 38 42
CEPHALEXIN 172 129 39 87
ALENDRONATE SODIUM 170 148 40 37
DONEPEZIL HCL 169 168 41 35
AZITHROMYCIN 169 119 41 41
DIGOXIN 169 164 41 59
ATORVASTATIN CALCIUM 167 140 44 18
PROMETHAZINE HCL 164 60 R 45 56
RISPERIDONE 163 135 46 71
TRIAMTERENE-HCTZ 163 113 46 48
TRAMADOL HCL 161 92 48 25
QUETIAPINE FUMARATE 144 128 49 70
CLONIDINE HCL 143 119 50 44
ENALAPRIL MALEATE 142 101 51 75
COMBIVENT 142 107 51 116
MECLIZINE HCL 133 118 53 113
PANTOPRAZOLE SODIUM 133 77 53 32
ACETAMINOPHEN-CODEINE 132 69 S3 55 163
LANTUS SOLOSTAR 129 109 56 112
GEMFIBROZIL 126 86 57 90
FLUTICASONE PROPIONATE 125 68 58 39
ADVAIR DISKUS 123 81 59 63
FAMOTIDINE 122 93 60 61
FLUOXETINE HCL 121 83 61 52
ZOLPIDEM TARTRATE 117 73 62 17
FINASTERIDE 114 108 63 121
METOPROLOL SUCCINATE 114 102 63 29
ISOSORBIDE MONONITRATE ER 112 98 65 66
FLUCONAZOLE 105 64 66 136
CARBIDOPA-LEVODOPA 105 73 66 108
SINGULAIR 104 67 68 82
CYCLOBENZAPRINE HCL 103 43 R 69 69
FENTANYL 98 45 S2 70 92
TRIAMCINOLONE ACETONIDE 97 78 71 159
LOVASTATIN 95 52 72 22
AMOX TR-POTASSIUM CLAVULANATE 94 78 73 106
MELOXICAM 94 84 73 20
METHOCARBAMOL 93 49 R 75 141
ENDOCET 93 17 S2 75 97
SPIRIVA 93 51 75 45
LOSARTAN-HYDROCHLOROTHIAZIDE 92 76 78 60
LEVOFLOXACIN 92 73 78 88
VENTOLIN HFA 91 62 80 93
AMOXICILLIN 90 51 81 119
PREMARIN 90 72 R 81 123
SULFAMETHOXAZOLE-TRIMETHOPRIM 90 58 81 89
OXYCODONE-ACETAMINOPHEN 88 61 S2 84 107
CELEBREX 86 55 85 131
HYDRALAZINE HCL 84 62 86 86
NAMENDA 81 73 87 49
CARVEDILOL 81 68 87 24
DICLOFENAC SODIUM 77 68 89 114
PHENYTOIN SODIUM EXTENDED 77 54 89 137
ALBUTEROL SULFATE 75 0 91 124
INSULIN SYRINGE 73 44 92 83
HYDROXYZINE HCL 73 57 R 92 151
CYMBALTA 72 50 94 53
OXYBUTYNIN CHLORIDE 70 59 95 115
NOVOLOG 70 36 95 139
DILTIAZEM ER 69 52 97 110
NITROSTAT 69 49 97 186
DIOVAN 68 39 99 58
DIOVAN HCT 67 67 100 103
NYSTATIN 66 52 101 132
LIPITOR 66 53 101 158
JANUVIA 66 46 101 85
CRESTOR 66 53 101 34
QUINAPRIL HCL 63 53 105 142
GENTAMICIN SULFATE 62 53 106 297
DOXAZOSIN MESYLATE 62 61 106 120
BENAZEPRIL HCL 60 44 108 38
PAROXETINE HCL 59 26 109 55
GLIMEPIRIDE 58 51 110 31
METOCLOPRAMIDE HCL 57 28 111 127
LACTULOSE 57 44 111 128
DOXYCYCLINE HYCLATE 57 41 111 94
LEVETIRACETAM 57 41 111 134
ESCITALOPRAM OXALATE 55 36 115 99
NITROFURANTOIN 54 33 116 187
BUMETANIDE 54 28 116 122
ROPINIROLE HCL 52 31 118 79
SEROQUEL 52 48 118 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.